Found: 21
Select item for more details and to access through your institution.
Challenges for patient selection with VEGF inhibitors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 151, doi. 10.1007/s00280-006-0403-6
- By:
- Publication type:
- Article
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 171, doi. 10.1007/s00280-006-0355-x
- By:
- Publication type:
- Article
Differential effects of the immunosuppressive agents cyclosporin A, tacrolimus and sirolimus on drug transport by multidrug resistance proteins.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 179, doi. 10.1007/s00280-006-0357-8
- By:
- Publication type:
- Article
Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 189, doi. 10.1007/s00280-006-0360-0
- By:
- Publication type:
- Article
Apoptosis induced by ID6105, a new anthracycline (11-hydroxyaclacinomycin X, Hyrubicin), and its anti-tumor effects on experimental tumor models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 197, doi. 10.1007/s00280-006-0361-z
- By:
- Publication type:
- Article
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 203, doi. 10.1007/s00280-006-0362-y
- By:
- Publication type:
- Article
The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 211, doi. 10.1007/s00280-006-0363-x
- By:
- Publication type:
- Article
Induction of oxidative damage by copper-based antineoplastic drugs (Casiopeínas<sup>®</sup>).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 219, doi. 10.1007/s00280-006-0364-9
- By:
- Publication type:
- Article
Antitumor activity of edotecarin in breast carcinoma models.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 229, doi. 10.1007/s00280-006-0365-8
- By:
- Publication type:
- Article
Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 237, doi. 10.1007/s00280-006-0366-7
- By:
- Publication type:
- Article
Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 245, doi. 10.1007/s00280-006-0367-6
- By:
- Publication type:
- Article
Tissue distribution in mice and metabolism in murine and human liver of apigenin and tricin, flavones with putative cancer chemopreventive properties.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 257, doi. 10.1007/s00280-006-0368-5
- By:
- Publication type:
- Article
Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 267, doi. 10.1007/s00280-006-0369-4
- By:
- Publication type:
- Article
The histone deacetylase inhibitor PXD101 synergises with 5-fluorouracil to inhibit colon cancer cell growth in vitro and in vivo.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 275, doi. 10.1007/s00280-006-0374-7
- By:
- Publication type:
- Article
Phase I study of TZT-1027, a novel synthetic dolastatin 10 derivative and inhibitor of tubulin polymerization, which was administered to patients with advanced solid tumors on days 1 and 8 in 3-week courses.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 285, doi. 10.1007/s00280-006-0382-7
- By:
- Publication type:
- Article
Erlotinib plus gemcitabine in patients with unresectable pancreatic cancer and other solid tumors: phase IB trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 295, doi. 10.1007/s00280-006-0389-0
- By:
- Publication type:
- Article
Dexamethasone as a probe for CYP3A4 metabolism: evidence of gender effect.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 2, p. 305, doi. 10.1007/s00280-006-0385-4
- By:
- Publication type:
- Article
The contribution of Gianni Bonadonna to the history of chemotherapy.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
- Published in:
- 2007
- By:
- Publication type:
- journal article
A first-in-man phase I tolerability and pharmacokinetic study of the cyclin-dependent kinase-inhibitor AZD5438 in healthy male volunteers.
- Published in:
- 2007
- By:
- Publication type:
- journal article
O6-benzylguanine and BCNU in multiple myeloma: a phase II trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article